Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease

References

• Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007;72(3):247-59
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J. Chronic kidney disease. Lancet 2012;379(9811):165-80
   PubMed Web of Science ®Google Scholar
• Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351(13):1296-305
   PubMed Web of Science ®Google Scholar
• Walker SR, Gill K, Macdonald K, et al. Association of frailty and physical function in patients with non-dialysis CKD: a systematic review. BMC Nephrol 2013;14:228
   PubMed Web of Science ®Google Scholar
• Etgen T, Chonchol M, Forstl H, Sander D. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol 2012;35(5):474-82
   PubMedGoogle Scholar
• Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006;17(7):2034-47
   PubMed Web of Science ®Google Scholar
• Kidney Disease: improving Global Outcomes. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013;3(1):1-150
   Google Scholar
• Black C, Sharma P, Scotland G, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess 2010;14(21):1-184
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139(2):137-47
   PubMed Web of Science ®Google Scholar
• Clement FM, Klarenbach S, Tonelli M, et al. An economic evaluation of erythropoiesis-stimulating agents in CKD. Am J Kidney Dis 2010;56(6):1050-61
   PubMedGoogle Scholar
• Winkelmayer WC, Owen WFJr, Levin R, Avorn J. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 2003;14(2):486-92
   PubMed Web of Science ®Google Scholar
• McLaughlin K, Manns B, Culleton B, et al. An economic evaluation of early versus late referral of patients with progressive renal insufficiency. Am J Kidney Dis 2001;38(5):1122-8
   PubMedGoogle Scholar
• Dalrymple LS, Katz R, Kestenbaum B, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med 2011;26(4):379-85
   PubMed Web of Science ®Google Scholar
• Klarenbach S, Tonelli M, Pauly R, et al. Economic evaluation of frequent home nocturnal hemodialysis based on a randomized controlled trial. J Am Soc Nephrol 2014;25(3):587-94
   PubMedGoogle Scholar
• Jain AK, Blake P, Cordy P, Garg AX. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol 2012;23(3):533-44
   PubMed Web of Science ®Google Scholar
• Yeates K, Zhu N, Vonesh E, et al. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 2012;27(9):3568-75
   PubMedGoogle Scholar
• Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol 2007;18(10):2644-8
   PubMedGoogle Scholar
• Baboolal K, McEwan P, Sondhi S, et al. The cost of renal dialysis in a UK setting – a multicentre study. Nephrol Dial Transplant 2008;23(6):1982-9
   PubMedGoogle Scholar
• Howard K, Salkeld G, White S, et al. The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton) 2009;14(1):123-32
   PubMedGoogle Scholar
• Kondo M, Yamagata K, Hoshi SL, et al. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol 2012;16(2):279-91
   PubMedGoogle Scholar
• Karopadi AN, Mason G, Rettore E, Ronco C. Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant 2013;28(10):2553-69
   PubMed Web of Science ®Google Scholar
• Lee H, Manns B, Taub K, et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 2002;40(3):611-22
   PubMed Web of Science ®Google Scholar
• Korevaar JC, Feith GW, Dekker FW, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003;64(6):2222-8
   PubMed Web of Science ®Google Scholar
• Weinhandl ED, Foley RN, Gilbertson DT, et al. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 2010;21(3):499-506
   PubMedGoogle Scholar
• Manns B, Johnson JA, Taub K, et al. Quality of life in patients treated with hemodialysis or peritoneal dialysis: what are the important determinants? Clin Nephrol 2003;60(5):341-51
   PubMedGoogle Scholar
• Gokal R, Figueras M, Olle A, et al. Outcomes in peritoneal dialysis and haemodialysis – a comparative assessment of survival and quality of life. Nephrol Dial Transplant 1999;14(Suppl 6):24-30
   PubMedGoogle Scholar
• Quinn RR, Ravani P, Hochman J. Technique failure in peritoneal dialysis patients: insights and challenges. Perit Dial Int 2010;30(2):161-2
   PubMedGoogle Scholar
• Liao CT, Chen YM, Shiao CC, et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant 2009;24(9):2909-14
   PubMedGoogle Scholar
• Chui BK, Manns B, Pannu N, et al. Health care costs of peritoneal dialysis technique failure and dialysis modality switching. Am J Kidney Dis 2013;61(1):104-11
   PubMed Web of Science ®Google Scholar
• Li PK, Chow KM. The cost barrier to peritoneal dialysis in the developing world – an Asian perspective. Perit Dial Int 2001;21(Suppl 3):S307-13
   Google Scholar
• Cueto-Manzano AM, Rojas-Campos E. Status of renal replacement therapy and peritoneal dialysis in Mexico. Perit Dial Int 2007;27(2):142-8
   PubMedGoogle Scholar
• McLaughlin K, Manns B, Mortis G, et al. Why patients with ESRD do not select self-care dialysis as a treatment option. Am J Kidney Dis 2003;41(2):380-5
   PubMedGoogle Scholar
• Hingwala J, Diamond J, Tangri N, et al. Underutilization of peritoneal dialysis: the role of the nephrologist’s referral pattern. Nephrol Dial Transplant 2013;28(3):732-40
   PubMedGoogle Scholar
• Mendelssohn DC, Mullaney SR, Jung B, et al. What do American nephologists think about dialysis modality selection? Am J Kidney Dis 2001;37(1):22-9
   PubMed Web of Science ®Google Scholar
• Komenda P, Gavaghan MB, Garfield SS, et al. An economic assessment model for in-center, conventional home, and more frequent home hemodialysis. Kidney Int 2012;81(3):307-13
   PubMed Web of Science ®Google Scholar
• Komenda P, Copland M, Makwana J, et al. The cost of starting and maintaining a large home hemodialysis program. Kidney Int 2010;77(11):1039-45
   PubMedGoogle Scholar
• Canadian Institute for Health Information. 2014 CORR Report: treatment of End-Stage Organ Failure in Canada, 2003 to 2012. Available from: https://secure.cihi.ca/free_products/2014_CORR_Annual_Report_EN.pdf
   Google Scholar
• Clark WR, Turk JEJr. The NxStage system one. Semin Dial 2004;17(2):167-70
   PubMedGoogle Scholar
• Walker R, Marshall MR, Morton RL, et al. The cost-effectiveness of contemporary home haemodialysis modalities compared with facility haemodialysis: a systematic review of full economic evaluations. Nephrology (Carlton) 2014;19(8):459-70
   PubMedGoogle Scholar
• Schachter ME, Tennankore KK, Chan CT. Determinants of training and technique failure in home hemodialysis. Hemodial Int 2013;17(3):421-6
   PubMedGoogle Scholar
• Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med 2006;354(10):997-9
   PubMed Web of Science ®Google Scholar
• Perico N, Bravo RF, De Leon FR, Remuzzi G. Screening for chronic kidney disease in emerging countries: feasibility and hurdles. Nephrol Dial Transplant 2009;24(5):1355-8
   PubMedGoogle Scholar
• Karopadi AN, Mason G, Rettore E, Ronco C. The role of economies of scale in the cost of dialysis across the world: a macroeconomic perspective. Nephrol Dial Transplant 2014;29(4):885-92
   PubMedGoogle Scholar
• Yu AW, Chau KF, Ho YW, Li PK. Development of the “peritoneal dialysis first” model in Hong Kong. Perit Dial Int 2007;27(Suppl 2):S53-5
   Google Scholar
• Lee CP, Zenios SA, Chertow GM. Cost-effectiveness of frequent in-center hemodialysis. J Am Soc Nephrol 2008;19(9):1792-7
   PubMedGoogle Scholar
• Gonzalez-Perez JG, Vale L, Stearns SC, Wordsworth S. Hemodialysis for end-stage renal disease: a cost-effectiveness analysis of treatment-options. Int J Technol Assess Health Care 2005;21(1):32-9
   PubMed Web of Science ®Google Scholar
• Mowatt G, Vale L, Perez J, et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Health Technol Assess 2003;7(2):1-174
   PubMedGoogle Scholar
• Prakash S, Austin PC, Oliver MJ, et al. Regional effects of satellite haemodialysis units on renal replacement therapy in non-urban Ontario, Canada. Nephrol Dial Transplant 2007;22(8):2297-303
   PubMedGoogle Scholar
• Diamant MJ, Harwood L, Movva S, et al. A comparison of quality of life and travel-related factors between in-center and satellite-based hemodialysis patients. Clin J Am Soc Nephrol 2010;5(2):268-74
   PubMedGoogle Scholar
• Malmstrom RK, Roine RP, Heikkila A, et al. Cost analysis and health-related quality of life of home and self-care satellite haemodialysis. Nephrol Dial Transplant 2008;23(6):1990-6
   PubMedGoogle Scholar
• Bernstein K, Zacharias J, Blanchard JF, et al. Model for equitable care and outcomes for remote full care hemodialysis units. Clin J Am Soc Nephrol 2010;5(4):645-51
   PubMedGoogle Scholar
• Soroka SD, Kiberd BA, Jacobs P. The marginal cost of satellite versus in-center hemodialysis. Hemodial Int 2005;9(2):196-201
   PubMedGoogle Scholar
• Knoll G. Trends in kidney transplantation over the past decade. Drugs 2008;68(Suppl 1):3-10
   PubMed Web of Science ®Google Scholar
• Knoll G, Cockfield S, Blydt-Hansen T, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ 2005;173(10):1181-4
   PubMed Web of Science ®Google Scholar
• Wolfe RA, Roys EC, Merion RM. Trends in organ donation and transplantation in the United States. 1999Am J Transplant 2010;10(4 Pt 2):961-72
   Google Scholar
• Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996;50(1):235-42
   PubMed Web of Science ®Google Scholar
• Manns B, Hemmelgarn B, Tonelli M, et al. Population based screening for chronic kidney disease: cost effectiveness study. BMJ 2010;341:c5869
   Google Scholar
• Barnieh L, Gill JS, Klarenbach S, Manns BJ. The cost-effectiveness of using payment to increase living donor kidneys for transplantation. Clin J Am Soc Nephrol 2013;8(12):2165-73
   PubMedGoogle Scholar
• Matas AJ, Schnitzler M. Payment for living donor (vendor) kidneys: a cost-effectiveness analysis. Am J Transplant 2004;4(2):216-21
   PubMed Web of Science ®Google Scholar
• Shepherd L, O’Carroll RE, Ferguson E. An international comparison of deceased and living organ donation/transplant rates in opt-in and opt-out systems: a panel study. BMC Med 2014;12(1):131
   PubMedGoogle Scholar
• Belasco A, Barbosa D, Bettencourt AR, et al. Quality of life of family caregivers of elderly patients on hemodialysis and peritoneal dialysis. Am J Kidney Dis 2006;48(6):955-63
   PubMed Web of Science ®Google Scholar
• Tsai TC, Liu SI, Tsai JD, Chou LH. Psychosocial effects on caregivers for children on chronic peritoneal dialysis. Kidney Int 2006;70(11):1983-7
   PubMedGoogle Scholar
• Wicks MN, Milstead EJ, Hathaway DK, Cetingok M. Subjective burden and quality of life in family caregivers of patients with end stage renal disease. ANNA J 1997;24(5):527-8; 531-8; discussion 539-40
   PubMedGoogle Scholar
• Komenda P, Ferguson TW, Macdonald K, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis 2014;63(5):789-97
   PubMedGoogle Scholar
• Kagoma YK, Weir MA, Iansavichus AV, et al. Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review. Am J Kidney Dis 2011;57(4):592-601
   PubMed Web of Science ®Google Scholar
• Jain AK, Cuerden MS, McLeod I, et al. Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD. Kidney Int 2012;81(12):1248-53
   PubMedGoogle Scholar
• Hemmelgarn BR, Zhang J, Manns BJ, et al. Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA 2010;303(12):1151-8
   PubMed Web of Science ®Google Scholar
• Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011;305(15):1553-9
   PubMed Web of Science ®Google Scholar
• Hoerger TJ, Wittenborn JS, Zhuo X, et al. Cost-effectiveness of screening for microalbuminuria among African Americans. J Am Soc Nephrol 2012;23(12):2035-41
   PubMedGoogle Scholar
• Boersma C, Gansevoort RT, Pechlivanoglou P, et al. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands. Clin Ther 2010;32(6):1103-21
   PubMedGoogle Scholar
• Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis 2010;55(3):463-73
   PubMedGoogle Scholar
• Peralta CA, Shlipak MG, Fan D, et al. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol 2006;17(10):2892-9
   PubMed Web of Science ®Google Scholar
• Tarver-Carr ME, Powe NR, Eberhardt MS, et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol 2002;13(9):2363-70
   PubMed Web of Science ®Google Scholar
• Hoy WE, Hughson MD, Singh GR, et al. Reduced nephron number and glomerulomegaly in Australian Aborigines: a group at high risk for renal disease and hypertension. Kidney Int 2006;70(1):104-10
   PubMedGoogle Scholar
• Zacharias JM, Young TK, Riediger ND, et al. Prevalence, risk factors and awareness of albuminuria on a Canadian First Nation: a community-based screening study. BMC Public Health 2012;12; 290-2458-12-290
   PubMedGoogle Scholar
• Levin A, Hemmelgarn B, Culleton B, et al. Guidelines for the management of chronic kidney disease. CMAJ 2008;179(11):1154-62
   PubMed Web of Science ®Google Scholar
• Virani S, Strong D, Tennant M, et al. Rationale and implementation of the SLICK project: screening for Limb, I-Eye, Cardiovascular and Kidney (SLICK) complications in individuals with type 2 diabetes in Alberta’s First Nations communities. Can J Public Health 2006;97(3):241-7
   PubMedGoogle Scholar